Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

IASO-782 in Systemic Lupus Erythematosus

his study is a randomized, double-blinded, and placebo-controlled phase Ia clinical study in subjects with SLE. The study is designed to assess the safety and tolerability of IASO-782 for the treatment of SLE.

Participants needed: 20
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai IASO Biotechnology Co., LtdUpdated: Aug 10, 2026Locations: 4
Eligibility criteria

Aged 18 to 75 years; [+6]

History of other primary malignant neoplasm within 5 years of screening; [+13]

Read more
Status: Recruiting

IASO-782 in Autoimmune Hematological Diseases

This study is a randomized, double-blinded, and placebo-controlled phase Ia clinical study in subjects with autoimmune hematological diseases. The study is designed to assess the safety and tolerability of IASO-782 for the treatment of autoimmune haematological diseases (ITP and wAIHA).

Participants needed: 16
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Shanghai IASO Biotechnology Co., LtdUpdated: May 29, 2026Locations: 2
Eligibility criteria

Age 18-65 years [+7]

History of other primary malignant neoplasm within 5 years of screening [+13]

Read more